Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Louzada-Junior, Paulo"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł :
2017 recommendations of the Brazilian Society of Rheumatology for the pharmacological treatment of rheumatoid arthritis.
Autorzy :
Mota LMHD; Programa de Pós-graduação em Ciências Médicas, Faculdade de Medicina- Universidade de Brasília; Serviço de Reumatologia, Hospital Universitário de Brasília, Universidade de Brasília, Brasília, Brazil. .; Rheos, Centro Médico Lúcio Costa, SGAS 610, bloco 1, salas T50- T51, L2 Sul, Asa Sul, Brasília, DF, 70200700, Brazil. .
Kakehasi AM; Disciplina de Reumatologia, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Gomides APM; Programa de Pós-graduação em Ciências Médicas, Faculdade de Medicina- Universidade de Brasília; Serviço de Reumatologia, Hospital Universitário de Brasília, Universidade de Brasília, Brasília, Brazil.; Centro Universitário de Brasília- UniCEUB, Brasília, Brazil.
Duarte ALBP; Universidade Federal de Pernambuco, Recife, Brazil.
Cruz BA; Hospital Vera Cruz, Belo Horizonte, Brazil.
Brenol CV; Serviço de Reumatologia, Departamento de Medicina Interna, Serviço de Reumatologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
de Albuquerque CP; Serviço de Reumatologia, Hospital Universitário de Brasília, Universidade de Brasília, Brasília, Brazil.
Castelar Pinheiro GDR; Disciplina de Reumatologia, Departamento de Medicina Interna, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Laurindo IMM; Universidade Nove de Julho, São Paulo, Brazil.
Pereira IA; Universidade do Sul de Santa Catarina, Florianópolis, Brazil.
Bertolo MB; Disciplina de Reumatologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, Brazil.
Ubirajara Silva de Souza MPG; Santa Casa de Belo Horizonte, Belo Horizonte, Brazil.
de Freitas MVC; Universidade de Fortaleza, Fortaleza, Brazil.
Louzada-Júnior P; Disciplina de Reumatologia, Faculdade de Medicina de Universidade de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
Xavier RM; Serviço de Reumatologia, Departamento de Medicina Interna, Serviço de Reumatologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Giorgi RDN; Serviço de Reumatologia, Hospital do Servidor Público Estadual de São Paulo, Instituto de Assistência Médica ao Servidor Público Estadual, São Paulo, Brazil.
Pokaż więcej
Źródło :
Advances in rheumatology (London, England) [Adv Rheumatol] 2018 May 24; Vol. 58 (1), pp. 2. Date of Electronic Publication: 2018 May 24.
Typ publikacji :
Journal Article; Practice Guideline
MeSH Terms :
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Brazil ; Decision Making ; Drug Substitution ; Drug Therapy, Combination/methods ; Glucocorticoids/administration & dosage ; Humans ; Hydroxychloroquine/therapeutic use ; Leflunomide/therapeutic use ; Methotrexate/therapeutic use ; Piperidines/therapeutic use ; Pyrimidines/therapeutic use ; Pyrroles/therapeutic use ; Rheumatology ; Societies, Medical ; Sulfasalazine/therapeutic use
Czasopismo naukowe
Tytuł :
Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis.
Autorzy :
Peres RS; Department of Pharmacology, Ribeirão Preto Medical School, Center of Research in Inflammatory Diseases (CRID), University of São Paulo, Avenida Bandeirantes, 3900, Ribeirão Preto, São Paulo, CEP: 14049-900, Brazil.
Santos GB; Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n, Ribeirão Preto, CEP: 14040-903, Brazil.
Cecilio NT; Department of Pharmacology, Ribeirão Preto Medical School, Center of Research in Inflammatory Diseases (CRID), University of São Paulo, Avenida Bandeirantes, 3900, Ribeirão Preto, São Paulo, CEP: 14049-900, Brazil.
Jabor VA; NPPNS, Department of Physics and Chemistry, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n, Ribeirão Preto, Brazil.
Niehues M; NPPNS, Department of Physics and Chemistry, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n, Ribeirão Preto, Brazil.
Torres BG; Pharmaceutical Sciences Graduate Program, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Sarmento Leite 521, Porto Alegre, Brazil.
Buqui G; NPPNS, Department of Physics and Chemistry, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n, Ribeirão Preto, Brazil.
Silva CH; Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n, Ribeirão Preto, CEP: 14040-903, Brazil.
Costa TD; Pharmaceutical Sciences Graduate Program, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Sarmento Leite 521, Porto Alegre, Brazil.
Lopes NP; NPPNS, Department of Physics and Chemistry, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n, Ribeirão Preto, Brazil.
Nonato MC; NPPNS, Department of Physics and Chemistry, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n, Ribeirão Preto, Brazil.
Ramalho FS; Department of Pathology, Ribeirão Preto Medical School, University of São Paulo, Avenida Bandeirantes 3900, Ribeirão Preto, Brazil.
Louzada-Júnior P; Department of Internal Medicine, Ribeirão Preto Medical School, Center of Research in Inflammatory Diseases (CRID), University of São Paulo, Avenida Bandeirantes 3900, Ribeirão Preto, Brazil.
Cunha TM; Department of Pharmacology, Ribeirão Preto Medical School, Center of Research in Inflammatory Diseases (CRID), University of São Paulo, Avenida Bandeirantes, 3900, Ribeirão Preto, São Paulo, CEP: 14049-900, Brazil.
Cunha FQ; Department of Pharmacology, Ribeirão Preto Medical School, Center of Research in Inflammatory Diseases (CRID), University of São Paulo, Avenida Bandeirantes, 3900, Ribeirão Preto, São Paulo, CEP: 14049-900, Brazil.
Emery FS; Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n, Ribeirão Preto, CEP: 14040-903, Brazil. .
Alves-Filho JC; Department of Pharmacology, Ribeirão Preto Medical School, Center of Research in Inflammatory Diseases (CRID), University of São Paulo, Avenida Bandeirantes, 3900, Ribeirão Preto, São Paulo, CEP: 14049-900, Brazil. .
Pokaż więcej
Źródło :
Arthritis research & therapy [Arthritis Res Ther] 2017 Mar 07; Vol. 19 (1), pp. 47. Date of Electronic Publication: 2017 Mar 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Arthritis, Experimental/*drug therapy
Arthritis, Rheumatoid/*drug therapy
Immunosuppressive Agents/*pharmacology
Naphthoquinones/*pharmacology
Animals ; CD4-Positive T-Lymphocytes/drug effects ; Cell Proliferation/drug effects ; Humans ; Lymphocyte Activation/drug effects ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Inbred DBA ; Molecular Docking Simulation ; Oxidoreductases Acting on CH-CH Group Donors/antagonists & inhibitors ; Rats ; Rats, Wistar
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies